Long-term effectiveness of live herpes zoster vaccine in patients with rheumatoid arthritis subsequently treated with tofacitinib
Open Access
- 11 March 2020
- journal article
- letter
- Published by BMJ in Annals Of The Rheumatic Diseases
- Vol. 79 (5), 669-671
- https://doi.org/10.1136/annrheumdis-2019-216566
Abstract
No abstract availableKeywords
Funding Information
- Pfizer Inc
This publication has 6 references indexed in Scilit:
- The Safety and Immunogenicity of Live Zoster Vaccination in Patients With Rheumatoid Arthritis Before Starting Tofacitinib: A Randomized Phase II TrialArthritis & Rheumatology, 2017
- Real-world comparative risks of herpes virus infections in tofacitinib and biologic-treated patients with rheumatoid arthritisAnnals Of The Rheumatic Diseases, 2016
- Risk of Herpes Zoster in Autoimmune and Inflammatory Diseases: Implications for VaccinationArthritis & Rheumatology, 2016
- 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid ArthritisArthritis Care & Research, 2015
- 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid ArthritisArthritis & Rheumatology, 2015
- Rheumatoid arthritis and herpes zoster: risk and prevention in those treated with anti-tumour necrosis factor therapyAnnals Of The Rheumatic Diseases, 2010